Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
A strategic thought partner for your AI journey
Explore our latest insights and perspectives in these life science resources, news articles, and events.
A biopharma client with an early clinical stage compound, showing efficacy across multiple neuropsychiatric conditions, wished to prioritize...
A large biopharma client objective aimed to optimize its omnichannel (OC) approach for HCP and patient Medical Education...
A top biopharma client wanted to understand diagnosis and treatment patterns for a rare respiratory disease only recently associated as a sequela....
A rare disease research consortium sought to identify barriers to adoption of AI-enabled, point-of-care diagnostic decision support tools..
A top biopharma client was in early-stage clinical development of an asset that showed efficacy in all-comers with the target disease, but even...
Designing a new GTM model for an ambitious upcoming oncology launch.
Assessing the opportunity and investment of AI and biomarker diagnostic solutions.
Putnam established technical feasibility for use of Gen AI to create Plain Language Summaries (PLS).
Putnam partnered with the client to understand the potential of the product for UC treatment to maximize its commercial impact.
We identified key stakeholders in priority markets, mapped out potential roles and evidence generation capabilities of identified KOLs.
We provided strategic recommendations to analyze and synthesize monthly observations and medical insights for a product.
We helped our client to understand what evidence is required to support vaccine technical committee approvals.
Looking to get in touch with an expert or team member?
Tell us how we can help.
